Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The RENEW Trial: A National, Multicenter Study of High-Dose Peginterferon Alfa-2B + Ribavirin for Non-Responders with Hepatitis C

The RENEW Trial: A National, Multicenter Study of High-Dose Peginterferon Alfa-2B + Ribavirin for Non-Responders with Hepatitis C. Hepatology. 2003; 38(4):312-13A.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.